These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 36782062)
1. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells. Hong Y; Yang Q; Song H; Ming GL Mol Psychiatry; 2023 Apr; 28(4):1430-1439. PubMed ID: 36782062 [TBL] [Abstract][Full Text] [Related]
2. New considerations for hiPSC-based models of neuropsychiatric disorders. Hoffman GE; Schrode N; Flaherty E; Brennand KJ Mol Psychiatry; 2019 Jan; 24(1):49-66. PubMed ID: 29483625 [TBL] [Abstract][Full Text] [Related]
3. Modeling neuropsychiatric disorders using human induced pluripotent stem cells. Wang M; Zhang L; Gage FH Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525 [TBL] [Abstract][Full Text] [Related]
4. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. van Hugte E; Nadif Kasri N Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501 [TBL] [Abstract][Full Text] [Related]
5. Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? Prytkova I; Goate A; Hart RP; Slesinger PA Alcohol Clin Exp Res; 2018 Sep; 42(9):1572-1590. PubMed ID: 29897633 [TBL] [Abstract][Full Text] [Related]
6. Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms. Flaherty EK; Brennand KJ Brain Res; 2017 Jan; 1655():283-293. PubMed ID: 26581337 [TBL] [Abstract][Full Text] [Related]
7. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes. Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622 [TBL] [Abstract][Full Text] [Related]
8. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective. Dalvi S; Galloway CA; Singh R Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384 [TBL] [Abstract][Full Text] [Related]
9. Modeling Disease with Human Inducible Pluripotent Stem Cells. Grandy R; Tomaz RA; Vallier L Annu Rev Pathol; 2019 Jan; 14():449-468. PubMed ID: 30355153 [TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. Pratumkaew P; Issaragrisil S; Luanpitpong S Cells; 2021 Nov; 10(11):. PubMed ID: 34831472 [TBL] [Abstract][Full Text] [Related]
12. Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells. Tobe BT; Snyder EY; Nye JS Curr Opin Pharmacol; 2011 Oct; 11(5):521-7. PubMed ID: 21723195 [TBL] [Abstract][Full Text] [Related]